Patent Assignment
Reel/Frame 053280/0305
Assignment of Assignor's Interest
Recorded: 2020-07-22
Pages: 6
Assignors
MOLLARD, ALEXIS
Executed: 2014-07-21
WARNER, STEVEN L.
Executed: 2014-07-21
FLYNN, GARY A.
Executed: 2014-06-25
VANKAYALAPATI, HARIPRASAD
Executed: 2014-06-24
BEARSS, DAVID J.
Executed: 2014-07-21
Assignee
TOLERO PHARMACEUTICALS, INC.
3900 N. TRAVERSE MOUNTAIN BLVD., LEHI, UTAH, 84043
Covered Property
(1)
JAK2 and ALK2 Inhibitors and Methods for Their Use
Application:
16/930,261 →
Publication:
US 2021/0070715
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger
Jul 22, 2020
From: TOLERO PHARMACEUTICALS, INC.
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 053280/0359 →
Change of Name
Jul 22, 2020
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 053283/0243 →
Change of Name
Apr 25, 2022
From: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA ONCOLOGY, INC.
Reel/Frame 059787/0758 →
Merger
Oct 23, 2023
From: SUMITOMO PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA AMERICA, INC.
Reel/Frame 065314/0430 →